Clinical Trial Update: SONOlysis in Risk REduction of Symptomatic and Silent Brain infarCtions dUring Cardiac surgEry [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on SONOlysis for risk reduction of symptomatic and silent brain infarctions during cardiac surgery, with completed status and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heart Valve Diseases

Snippet

Sponsor: University Hospital Ostrava | Conditions: Coronary Artery Bypass Graft Redo, Heart Valve Diseases | Phase 3 | Status: COMPLETED | Results posted: 2016-09-08